Halozyme Therapeutics | Beneficio Operativo



Operating Profit Cambio Fecha
Acadia Pharmaceuticals USD 19.29M 134.21M 2025-03
Agios Pharmaceuticals USD -106629000 18.41M 2025-03
Alnylam Pharmaceuticals USD 18.08M 123.24M 2025-03
Amarin USD -25168000 24.64M 2024-09
Amgen USD 1.29B 1.02B 2025-03
Baxter International USD -435000000 590M 2024-12
Cytokinetics USD -155631000 16.59M 2025-03
DBV Technologies USD -30328000 3.51M 2024-09
Eli Lilly USD 5.41B 259.6M 2025-03
Halozyme Therapeutics USD 141.54M 33.97M 2025-03
Indivior 66M 226M 2025-03
Ionis Pharmaceuticals USD -146000000 35.18M 2025-03
MannKind USD 22.29M 9.19M 2025-03
Pfizer USD 3.67B 4.08B 2025-03
United Therapeutics USD 382.8M 25.1M 2025-03



Halozyme Therapeutics Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - May 2025.